| 133040-01-4 Basic information More.. |
Product Name: | EPROSARTAN | Synonyms: | 4-[2-Butyl-5-(2-carboxy-3-thiophen-2-yl-propenyl)-imidazol-1-ylmethyl]-benzoic acid;EPROSARTAN;Eprosartan Mysylate;(E)-3-[2-Butyl-1-[(4-carboxyphenyl)-methyl]imidazol-5-l]-2-(2-thienylmethyl)-2-propenoic Acid;((E)-3-[2-Butyl-1-[(4-carboxyphenyl)methyl]imidazol-5-yl]-2-(2-thienylmethyl)-2-propenoic Acid;SKF-108566);SKF-108566J;Teveten | CAS: | 133040-01-4 | MF: | C23H24N2O4S | MW: | 424.51 | EINECS: | | Mol File: | 133040-01-4.mol |  |
Use
Eprosartan is a prototype of the imidazoleacrylic acid angiotensin II receptor antagonists. Eprosartan is an antihypertensive.
- Eprosartan
-
- US $0.00-0.00 / mg
- 2025-02-22
- CAS:133040-01-4
- Min. Order: 10mg
- Purity: 98
- Supply Ability: 10000000
- Eprosartan
-
- US $39.00-105.00 / mg
- 2024-11-13
- CAS:133040-01-4
- Min. Order:
- Purity: 100%
- Supply Ability: 10g
- Eprosartan
-
- US $0.00-0.00 / Kg
- 2020-05-10
- CAS:133040-01-4
- Min. Order: 1KG
- Purity: 99.0%
- Supply Ability: 500 MT
|
133040-01-4
Recommend Suppliers |
|